| Product Name | NebuSelect™ Recombinant Human Siglec-5/CD170, hFc-tag |
|---|---|
| Catalog Number | NBL-242115 |
| Alias/Synonyms | Siglec-5/CD170; CD170; CD33 antigen-like 2; CD33L2; OBBP2; Siglec5; SIGLEC5; OB-BP2 |
| Appearance | see COA |
| Molecule Weight | Glu17-Thr434 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | O15389 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242115-100ug | 100ug | Inquire | Inquire | |
| NBL-242115-1mg | 1mg | Inquire | Inquire | |
| NBL-242115-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Siglec-5/CD170, hFc-tag
Catalog#:
NBL-242115
Description:
NebuSelect™ Recombinant Human Siglec-5/CD170, hFc-tag(Cat#NBL-242115) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Glu17-Thr434.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 73.1 kDa. Due to glycosylation, the protein migrates to 90-115 kDa based on Bis-Tris PAGE result.
Target Name:
Siglec-5/CD170; CD170; CD33 antigen-like 2; CD33L2; OBBP2; Siglec5; SIGLEC5; OB-BP2
Target Information:
Interactions between endothelial selectins and the leukocyte counter-receptor PSGL1 mediates leukocyte recruitment to inflammation sites. PSGL1 is highly sialylated, making it a potential ligand for Siglec-5, a leukocyte-receptor that recognizes sialic acid structures. Binding assays using soluble Siglec-5 variants (sSiglec-5/C4BP and sSiglec-5/Fc) revealed a dose- and calcium-dependent binding to PSGL1.
Amino Acid Sequence:
Glu17-Thr434
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.